Cargando…
Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours
SIMPLE SUMMARY: Using immune cells to treat cancers is a promising new approach for leukemias and lymphomas. However, the use of cellular therapy in solid tumours is compromised by poor migration to the tumour, the physical barriers to infiltration, and the active suppression by the tumour. We will...
Autores principales: | White, Lydia G., Goy, Hannah E., Rose, Alinor J., McLellan, Alexander D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870056/ https://www.ncbi.nlm.nih.gov/pubmed/35205725 http://dx.doi.org/10.3390/cancers14040978 |
Ejemplares similares
-
CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021) -
Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
por: Donnadieu, Emmanuel, et al.
Publicado: (2020) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021) -
Promoter choice: Who should drive the CAR in T cells?
por: Rad S. M., Ali Hosseini, et al.
Publicado: (2020) -
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
por: Zhang, Angela Q., et al.
Publicado: (2023)